|
Prevention
and Vaccination > HBF Vaccine Watch
HBF Vaccine Watch
| NAME |
TYPE VACCINE |
COMPANY |
STATUS |
| Hepatitis B Vaccines
- Recommended for those at risk and patients
with chronic HCV |
| Engerix B |
Recombinant HBV |
GlaxoSmithKline,
Philadelphia, PA |
Market, USA |
| Recombivax
HB |
Recombinant HBV |
Merck,
West Point, PA |
Market, USA |
| Gen Hevac B |
Recombinant HBV |
Aventis
Pasteur, Lyons, France |
Market, Europe |
Hepacare
(formerly, Hepagene) |
HBV preS1, preS2 |
PowderJect,
Oxford, U.K. |
Market, Europe |
| Bio-Hep B |
HBV S, preS1, PreS2 |
Biotech.
Gen. Corp., Iselin, N.J. |
Market, Israel |
| Hepavax Gene |
Recombinant HBV |
Berna
Biotech, Switzerland |
Market, Europe |
| Hepatitis A Vaccines
- Recommended for those at risk and patients
with chronic HBV and HCV |
| Havrix |
Inactivated HAV |
GlaxoSmithKline |
Market, USA |
| VAQTA |
Inactivated HAV |
Merck |
Market, USA |
| Avaxim |
Inactivated HAV |
Aventis
Pasteur |
Market, Europe |
| Combination Hepatitis
Vaccines |
| TwinRix (Adult) |
HBV and HAV |
GlaxoSmithKline |
Market, USA |
| Comvax (Pediatric) |
HBV and HiB |
Merck |
Market, USA |
| Pediarix (Pediatric) |
HBV, Polio, DTP |
GlaxoSmithKline |
Market, USA |
| Hexavac (Pediatric) |
HBV, DTP, HiB, Polio |
Aventis
Pasteur |
Market, Europe |
| Hepatitis Vaccines
in Development |
Extra Strength Hep B
(for poor or nonresponders) |
Recombinant |
GlaxoSmithKline
(with Corixa) |
Phase III |
| Hep B Vaccine |
ISS-linked to HBsAg |
Dynavax
Technology, Berkley, CA |
Phase I/II |
Hep B
DNA Vaccine Px |
HBV DNA Vaccine |
PowderJect |
Phase I |
|
 
|
